In addition, although adiposity might be an important modifier of adverse outcomes in CKD[7, 23], Rhee et al. supported that higher adiponectin remained associated with mortality in HD patients even under comprehensive adjustment for body anthropometry[6]. The gene discussed is ADIPOQ; the disease is chronic kidney disease.